|
| AWZ1066S Basic information |
Product Name: | AWZ1066S | Synonyms: | AWZ1066S;AWZ1066S;AWZ-1066S;AWZ 1066S;Pyrido[2,3-d]pyrimidin-4-amine, 2-[(3S)-3-methyl-4-morpholinyl]-N-[[2-(trifluoromethyl)-3-pyridinyl]methyl]-;2-[(3S)-3-Methyl-4-morpholinyl]-N-[[2-(trifluoromethyl)-3-pyridinyl]methyl]pyrido[2,3-d]pyrimidin-4-amine;oral,Inhibitor,anti-Wolbachia,Onchocerciasis (river blindness),CYP3A4,AWZ1066S,Parasite,AWZ-1066S,CYP2C9,tropical diseases,inhibit,lymphatic filariasis (elephantiasis) | CAS: | 2239272-16-1 | MF: | C19H19F3N6O | MW: | 404.39 | EINECS: | | Product Categories: | | Mol File: | 2239272-16-1.mol | |
| AWZ1066S Chemical Properties |
storage temp. | Store at -20°C | solubility | DMSO : 125 mg/mL (309.11 mM; Need ultrasonic) |
| AWZ1066S Usage And Synthesis |
Biological Activity | AWZ1066S is a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis, with an EC50 of 2.5 nM in cell assay[1]. | References | [1]. Hong WD, et al. AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis. Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1414-1419. |
| AWZ1066S Preparation Products And Raw materials |
|